Rewald E, L. Barberis, Francischetti MM. Asymmetry alters immune-partner
relationship - Cellular and Molecular Biology 50, Online 2004;30:
OL515-OL516
Rewald E, Francischetti MM. After eight-year-tolerance minimal i.v.
anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic
purpura (ITP) Transf Apheresis Sci 2004;30(2): 105-110
Lorenzo M, Sánchez PA, Rewald
E. Noise and microflora behavior. New York 2003, Oral Tolerance:
mechanisms and applications; NY Acad Sci. Conference.
Sánchez PA, Lorenzo M, Rewald
E. Stochastic resonance-like phenomena in context of the alimentary
tract. New York 2003, Oral Tolerance: mechanisms and applications;
NY Acad. Sci. Conference.
Amital H, Rewald E, Manthorpe R, Engervall P , Sherer Y, Langevitz
P, Levy Y, Bar-Dayan Y, Shoenfeld Y. Fibrosis regression induced
by intravenous gammaglobulin treatment Ann rheum dis 2003;62:175–177
Rewald E, Francischetti MM. Methotrexate treatment and mortality
in rheumatoid arthritis. Lancet. 2002 Oct 5;360(9339):1097
Rewald E, Francischetti MM, Barberis L. High dose intravenous immunoglobulin
repertoire versus anti-D. Disproportions in quantity and quality.
Cell Mol Biol (Noisy-le-grand). 2002 May;48(3):265-9.
Rewald E. Is an understanding of intravenous anti-D minidose mechanism
again on the move? Vox Sang 2002 Aug;83(suppl 2): abstr 689 [27th
Congress ISBT, Vancouver].
Rewald E. Inflammatory elements
and the APS. Lupus 2002;11(9):581 [abstr 10th Int Congress APS,
Taormina].
Rewald E. El abismo entre las dosis de gammaglobulina IV en la púrpura
trombocitopénica idiopática y en las enfermedades
autoinmune inflamatorias. Por invitación XII Mitin Internacional
de Asma, Alergia e Inmunología 2002, Buenos Aires.
Rewald E. Mecanismo de acción de la inmunoglobulina intravenosa.
Por invitación. Ateneo Científico, As Arg Alergia
e Inmunología Clínica 2002, Buenos Aires.
Rewald E, Francischetti MM, Nydegger UE. IVIG-pools: regulatory
gifts. Transiting from harmony toward harmonious immunoglobulins:
why? And why not? Transfus Apheresis Sci 2001 Oct;25(2):143-137
Review.
Rewald E. IVIG as a nonspecific accelerator of restitutio ad integrum.
Transfus Sci. 2000 Oct;23(2):163-164
Rewald E, Francischetti MM. Defense system shortcuts and limits
of scope. Med Hypotheses 2000;55(4):277-282. Review.
Rewald E. Intravenous
immunoglobulin ÏVIG Contribution to natural healing. World
Congress on
C ellular and Molecular Biology. 8-15-2000, Jena, Germany.
Rewald E. IVIG as a nonspecific accelerator of restitutio ad integrum.
Transfus Sci. 2000;23(2):163-164.
Rewald E, Francischetti MM, González C. Antifibrotic tendency
as complement to inflammatory burnout? Six year IVIG treatment in
a case with atherosclerosis and chronic hepatitis C. Transfus Sci.
1999 Aug;21(1):3-5.
Rewald E, Francischetti MM, González C. No man is an island;
no island is an island: does the immune network extend beyond the
limits of skin? Med Hypotheses 1999; 52(4):325-327. Review.
Rewald E. Immune Crossover - The Two Faces of Immunity. Book Presentation:
Universität Heidelberg, Transplantationsimmunologie [May 15,
1999].
Immune Crossover - The Two Faces of Immunity. Carnforth, London,
New York 1998, Parthenon Publishing Group.
Rewald E. Immune Crossover. CM Publicación Médica
1998;11(1):79.
Rewald E. Aspectos relacionados con inmunoglobulinas intravenosas.
Hemotécnica 1998;8(3):21-29.
Rewald E, Francischetti MM. Combining interferon-alpha2b (IFN) and
intravenous immunoglobulins IgG, IgM and IgA (IVIG) in rapid progressive
myelofibrosis (MF) with Trisomy 1. Letter. Am J Hematol 1997Apr;54(4):340.
Rewald E, Pizzolato M, Bragantini G, Saito N. Platelet-less bleeding
prevention by intravenous IgG (IVIG) until IgG complexes with IgM.
Interlake’s Fourth Int Symp IVIG,1996.
Rewald E, González CA. Combining IgG and interferon alpha-2
in chronic hepatitis C virus infection. Interlake’s Fourth
Int Symp IVIG, 1996.
Rewald E, Pizzolato M, Bragantini G, Saito N. Plateless-bleeding
prevention by intravenous IgG (IVIG) until IgG complexes with IgM.
Singapore 1996 XXVIth Congress Int Soc Hematol.
Saito, N., Rewald, E., Takemori, N., Kohgo, Y., Asaka, M. - Ultrastructural
localization of human IgG in bone marrow cells after intraperitoneal
injection of human IgG in mice; comparison with human albumin. XXVIth
Congress Int Soc Hematol 1996, Singapore.
Rewald E, González C. Combining IgG and interferon alpha-2b
in chronic hepatitis C virus infection. Transfus Sci 1996;Sep; 17(3):433-436.
Nydegger UE, Rewald E. Anti-D-Rho immunoglobulin: a viewpoint. Clin
Immunotherapeutics 1996;5:491.
Rewald E. Therapeutic Immunomodulation by gammaglobulin. 1996 [Seminar
by invitation] Prof P Terness, Transplantationsimmunologie., Universität
Heidelberg.
Rewald E, González C. Nuestra red inmune ¿trasciende
la piel? CM Publicación Médica 1996;9(2):112-113.
Rewald E, Saito N, Kohgo Y. Spontaneous bleeding prevention by gammaglobulin
infusions? Rev Iberoamer Tromb Hemost 1995;8 (Supl 3):101.
'Chasing after the Molecule' Video-film 58’ [English, Español]
1995, Wien, Good Day Film Production, Kräftner & Wagenhofer.
E. Rewald interviewing M. Kazatchkine (Paris), P Terness (Heidelberg),
UE, Nydegger (Bern) N Saito (Sapporo), E Gelfand (Denver), M Basta
(Bethesda).
Rewald E, Saito N, Kohgo Y, Takemori N. Is intravenous albumin a
placebo? Lancet 1995;346:1497, letter.
Rewald E. Are there options for donor-derived i.m. anti-D IgG preparations
other than to prevent Rh(D) sensitization? The int-ravenous route.
Transfus Sci 1995;16(4) :383-389 review.
Rewald E. El médico como investigador. CM Publicación
Médica 1995;8(1):38-40.
Rewald E. The GP as researcher in medicine (by invitation) 25th
anniversary of Ludwig Heilmeyer's death, Commemorative Symposium
1994, Jena.
Rewald E, Bendersky E. Intrathecal IgG for ALS.
Neurology. 1994 Aug;44(8):1554-1555, letter.
ICSH recommendations for measurement of erythrocyte sedimentation
rate. International Council for Standardization in Haematology (Expert
Panel on Blood Rheology, chairman E. Rewald) J Clin Pathol. 1993
Mar;46(3):198-203.
Rewald E. Immunomodulation by massive doses of Intravenous Immunoglobulin
(IgG). Plenary Lecture, XXth Congr. Int. Soc. Blood Transf.,
Sao Paulo 1992 [Rev Soc Brasil Hematol & Hemoter 1992;14:1993].
Rewald E. Preface, pp 11-13; Control of spontaneous haemorrhage
without normalization of haemostatic defect? an endothelial effect?
pp 57-62; Immunoglobulins in autoimmune disease. pp 191-202. In
Immunomodulation by Intravenous Immunoglobulin 1993 Rewald E, Morell
A (eds), Carnforth, New York. The Parthenon Publishing Group.
Rewald E. Intento de Síntesis: Inmunomodulación Terapéutica.
Conceptos Actuatuales. Int Conf Inmunomodulation 1993, Mar del Plata.
Rewald E. Prueba de Coombs Positiva Transitoria Durante la Remisión
de Enfermedad de Hodgkin [mesa redonda] Soc Med Int 1993, Mar del
Plata.
Rewald E. ‘Fundamento y Protocolo de la Evaluación de
un Posible Efecto Endotelial de la IgG. 1993 [por invitación]
Instituto de Hematología y Hemoterapia, Universidad de Córdoba
[prof Héctor Bepré Becerra].
Rewald E. Intravenous Immunoglobulin and Spontaneous Haemorrhage
in a Case of Factor VIII Inhibitor. [Br J Haematol, special issue,
abstr 1596]. XXIVth Congress Int Soc Hematol 1992, London.
Rewald E. Attempt to Prolong Remission in Low-Grade B-Cell Lymphoma
with a-2 Interferon and Levamisole. [Br J Haematol Special Issue,
abstr. 1213]. XXIVth Congr Int Soc Haematol 1992, London.
Rewald E. Immunomodulation by massive doses of Intravenous Immunoglobulin
[by invitation] XXth Congress Int Soc Blood Transf 1992, Sao Paulo.
Rewald E, IVIgG in the treatment of D-alloimmunized pregnant women
[Historians Corner], Transfusion Today 1991 No 11/Sep pp 8-9; Quarterly
Newsletter Int. Soc Blood Transf (English, French & Spanish).
Rewald E. A vascular effect of IgG therapy may prevent transplacental
red cell leakage and spontaneous thrombocytopenic haemorrhages.
Med Hypotheses. 1990 Nov;33(3):193-195.
Rewald E, Jaksic JC, Behcet's syndrome treated with high-dose intravenous
IgG and low-dose aspirin. J R Soc Med. 1990 Oct;83(10):652-3.
Rewald E. Citoquinas: revisión general y aplicaciones hematológicas.
XIIth Congresso Nacional del Colegio Brasileiro de Hematologia 1989,
Fortaleza. [Informe Cientifico Dic/89 En/90, Fundaçao Maria
Cecília Souto Vidigal].
Rewald E. IVIG como Tratamiento de la Embarazada Sensibilizada al
Rh del Feto. II° Congreso Arg Hemoterapia & Inmunohematol
1988, Mar del Plata.
Rewald E. High-dose intravenous IgG preceded by plasmapheresis as
prevention of stillbirth in Rh-incompa-tibility (abstr. OP-M-6-8)
XXIIth Congress Soc Int Hematol 1988, Milano.
Rewald E. Repeated low doses of anti-rhesus gammaglobulin in aplastic
anaemia. Lancet. 1987 Oct 3;2(8562): 795 letter.
Rewald E. Tratamiento con anti-D gammaglobulina en anemia aplástica.
(abstract D 78) VIII° Congreso Arg Hematol 1987, Salta.
Rewald E. Intravenous gammaglobulin to prevent stillbirth in rhesus
incompatibility. Lancet 1985 Jul 27;2(8448):208[letter].
Rewald E, Estévez ME, Sen L. Monoclonal B-cell lymphocytosis
in early childhood. A case report. Am J Pediatr Hematol Oncol. 1985
Winter;7(4):331-335.
Rewald E. Hämorrheologischer Einfluss des Hämatokritwertes
auf die Hirndurchblutung [by invitation, Prof Lechner] Psychiatrisch-Neurologische
Universitäts-klinik 1985 Graz.
Rewald E, Estévez ME, Sen L. Monoclonal B-cell lymphocytosis
in early child hood. Am. J. Pediat. Hematol.& Oncol. 1985; 7:331.
Rewald E. Incompatibilidad materno-fetal. Soc Obstetricia y Ginecología
1985, Mar del Plata.
García Rosasco M, Rewald E. Red cell filtration time in the
rat related to anemic, normal, and polycythemic hematocrit. Clin
Hemorrheol 1984;4:87-89.
Rewald E, Estévez ME, Sen L. Monoclonal B-cell lymphocytosis
in early childhood. XXth Congress Int Soc Hematol 1984, Buenos Aires.
García Rosasco, M., Rewald E. Red cell filtrability in anemic
and polycythemic acquired states in rats. XXth Congress Int Soc
Hematol 1984, Buenos Aires.
ESR & Plasma Viscosity Expert Panel [Rewald E, chairman]. Recommendation
for a selected method for the measurement of plasma viscosity. ICSH.
J. Clin Pathol 1984 Oct;37(10):1147-1152.
Rewald E, The influence of haematological diseases on haemorheology
[by invitation]. Vth South-East European Neuropsychiatry Conference
1983, Graz [Proceedings I pp 600].
Rewald E, García Rosasco M. Red cell filtration time. Its
correlation to venous hematocrit in normal young men. Clin. Hemorrheol
1982;2:249-251.
Rewald E, García Rosasco, M. - Tiempo de filtración
y su relación con la concentración de glóbulos
rojos. International Symposium on blood fluidity 1982, Fundación
Hematológica, Mar del Plata.
Estévez ME, Diez RA, Bellouard A, Delgado J, Rewald E, Sen
L. Phenotypic characterization and functional study in Sezary syndrome
(SS).XIIIth Int Cancer Congress 1982 Seattle.
Rewald E, García Rosasco M. Delay in red cell filtration
in polycythaemic patients. Br J Haematol 1981
Mar;47(3):485 letter.
Rewald E, García Rosasco M. Delay in red cell filtration
in polycythaemic patients. Abstr 58, pp 29. II European Conference
on Clinical Haemorheology 1981, London.
Rewald E, García Rosasco M. Relación entre el tiempo
de filtración de glóbulos rojos y el hematocrito en
varones normales. VI° Congreso Arg Hematol 1981, Mendoza.
Rewald E. Esplenectomía en anemia aplástica. VI°
Congreso Arg Hematol 1981, Mendoza.
Rewald E, Estévez ME, Sen L. Leucemia linfática crónica
en la niñez. VI° Congreso Arg Hematol 1981, Mendoza.
Rewald E. Splenic alterations during clinical remission of lymphoma.
XVIIIth Congress Soc. Int. Hematol 1980, Montreal.
Rewald E, García Rosasco M. Flunarizine y Polycythemia. Int
Symposium on Blood Viscosity 1980, Fundación Hematológica,
Mar del Plata.
Rewald E, García Rosasco M. Alteración de la flexibilidad
de membrana en glóbulos rojos de pacientes con poliglobulia.
Med Atlántico 1980;21:672.
Rewald E. Alteraciones del bazo concomitantes con la remisión
clínica de linfoma V° Congreso Arg Hematol 1979 (abstr
F4 p37), Neuquén.
Rewald E. Neutropenia y monocitopenia bien toleradas [Well tolerated
neutropenia and monocytopenia (author's transl)]. Sangre (Barc)
1977;22(3)389-392 Spanish.
Rewald E. Oxymetholone in chronic hypoplastic neutropenia XVIth
Congress Soc Int Hematol 1976 (abstr 4-127, p175-176), Kyoto.
Rewald E, Moscardi F. Chronic granulocytopenia and monocytopenia
with apparent good health. Lancet 1975 Nov 8;2 (7941):935, letter.
Rewald E. Neutropenia. Soc Med Interna Mar del Plata, 1975.
Rewald E. La enfermedad de letterer Christian (Histiocitosis X)
[Letterer-Christian's disease (histiocytosis X)]. Sangre (Barc).
1975;20(2):89-100. Spanish.
Rewald E. Rheumatoid arthritis and lymphoma. Int Congress of lymphology
abstr 1975, Buenos Aires.
MK Informationen [news from Med Klin]: Besserung der rheumatoiden
Arthritis durch BCG-Impfung information [Improvement of rheumatoid
arthritis by BCG vaccination] Rewald E. Lancet 1974;2:785. German.
Rewald E. BCG in rheumatoid arthritis. Lancet 1974 Sep 28;2(7883):785-6,
letter.
Rewald E. Neutropenia crónica tratada con inmunosupresores.
IV° Congresso do Colégio Brasileiro de Hematologia 1973,
Curitiba.
Rewald E. Artritis reumatoidea y linfoma. Primera Jornada Bonaerense
de Hematol Hemoter 1973, Mar del Plata.
ESR expert panel (Rewald, E. Chairman). Reference method for the
erythrocyte sedimentation rate (ESR) test on human blood. ICSH.
Br J Haematol. 1973 May;24(5):671-673.
Rewald E. Leucemia e inmunidad. III Congresso do Colégio
Brasileiro de Hematol 1971 [Anais 102ª]. Belo Horizonte.
Rewald E. Hemorragia. Soc Med Interna. Mar del Plata, 1971.
Rewald E, Moscardi F. Burning mortality in rats influenced by hematocrit
level. Preliminary report.Haematol Lat. 1971 Jul-Sep;13(3):233-236.
Rewald E. Improved work capacity at altitude by transfusional polycythemia.
J.Sports Med 1970 Jun;10(2):96-99.
Rewald E, Moscardi F. Burning mortality in rats influenced by red
cell mass. XIIIth Congress Soc Int Hematol 1970, M?nchen.
Rewald E. Funciones de los glóbulos rojos además del
intercambio gaseoso. Su importancia. [por invitación] Primeras
Jornadas Hematológicas Internacionales 1969, Mérida
[Rev Soc Mex Hematol 1971;1:85].
Rewald E, Lascano, E. - Trombocitopenia esencial en paciente autoesplenectomizada.
Primeras Jornadas Hematológicas Internacionales 1969, Mérida.
[Rev Soc Mex Hematol 1971;1:44].
Rewald E. Moscardi F. Influencia de la masa eritrocitaria sobre
la mortalidad de quemaduras en ratas.Congreso Arg Ciencias Biol.
[Acta p 213] 1970, Buenos Aires
Rewald E. Transfusión de sangre como tratamiento [por invitación].
Curso de Hematología Pediátrica 'Ateneo de Pediatría
León Velasco Blanco' 1969, Buenos Aires
Rewald E. Rendimiento deportivo en la altura. Poliglobulia por transfusión
y ca pacidad de trabajo. XII Congreso Arg Medicina del Deporte.
1969 [Deporte 1969 pp31], Buenos Aires.
Azcarruns C, Ergueta M, Hurtado L, Rewald E. Red cell transfusion
in infected infants at altitude. Experimental basis IV for ‘substitutive-inhibitor’
y transfusions. Helv Paediatr Acta 1969 Aug;24(4):420-2.
Rewald E, Martínez Lora SL. Red cell transfusion in infected
infants. Experimental basis III for 'substitutive-inhibitory’
transfusions. Helv Paediatr Acta 1968 Oct; 23(5):525-8.
Rewald E. La médula ósea en perspectiva. [The bone
marrow in perspective] Sangre (Barc)1968;13(3):247-64 (Spanish).
Rewald E, Suringar F. Tolerance of intravenous gamma globulin. In
Bibl Haematol N° 2 9 (P1) Karger, Basel/New York 1968; pp:337-339.
Rewald E. Neutrophilic marrow discharge influenced by erythroid
stimulation and suppression. Experimental basis II for Substitutive-Inhibitory
Transfusions. XIIth Congress Int. Soc. Hematol 1968, New York.
Rewald E. Poliglobulia por transfusión y capacidad de trabajo
en la altura.. Prensa Méd Boliviana 1968 Set-Oct; 20(5):133-136.
Rewald E. La enfermedad esferocítica (por invitación).
XVIIIas J Soc Arg Pediatría 1968, Rosario.
Rewald E. Mecanismo de regulación de la hemopoyesis y aplicaciones
clínicas experimentales (por invitación). IVas J Venezolanas
de Hematol y Transf 1968, Caracas.
Rewald E, Pellitero, C. Agglutinin synthesis regulation independent
of antigen. Acta Haematol.1967;37(1):62-4.
Rewald E. Das Organ Knochenmark. (editorial) [The organ bone marrow]
Med. Klin 1967 Jul 21;62(29):1113-1117 (German).
Rewald E. Das Organ Knochenmark. [editorial] Med. Klin. 1967 Jul
21;62(28):1077-8 German.
Rewald, E. - La médula ósea en perspectiva. [Relato]
II° Congreso Chileno Hematol 1967.Valparaíso..
Rewald E. Hemopatía maligna sin temor. II° Congreso Chileno
Hematol 1967, Valparaíso.
Rewald E, Chiodi, AO, Suringar F. Rebound phenomenon after depression
of gamma globulin synthesis. XIth Congress Int. Soc. Hematol 1966,
Sydney.
Rewald E, Suringar, F. Chiodi, A.O., Rodríguez, J. - El catabolismo
fraccional de la gamma globulina y su dependencia de la concentración.
II° Congreso Arg.Hematol 1966, Córdoba.
Rewald E, Suringar F. Substitutive-inhibitory gamma globulin therapy
as prevention of stillbirth in Rh-incompatibility. Acta Haematol.
1965 Oct;34(4):209-14.
Rewald E. Evaluation and selection of patients for "substitutive-inhibitory
therapy" in thalassemia and sickle cell disease. Isr J Med
Sci. 1965 Jul;1(4):782-783.
Rewald E., Barbini A, Moreno V. Experimental Basis for "Substitutive-inhibitory
Therapy" in constitutional hemolytic disease. Israel J. Med
Sci 1965 Jul;1(4):780-782.
Rewald E. ‘Substitutiv-Inhibitorische Transfusionen’ bei
schweren Erythropathien [Substitutive-inhibitory transfusion in
severe erythropathies]. Med Klin 1965 Oct 15; 60(42):1690-1692.
[German].
Rewald E. ‘Substitutiv-Inhibitorische Therapie’ bei haem-olytischer
Erkrankung ["Substitutive-inhibitory therapy" in hemolytic
disease. Experimental bases]. Med Klin 1965 Jul 9; 60(28):1117-1122
[German].
Rewald E. La eritropoyesis hiperactiva como causa de distrofia.
Arch Arg Pediatría 1964;40:90-101.
Rewald E. Collapse curve of normal red cell survival after massive
transfusion. 10th Congress Int Soc of Haematol 1964, Stockholm.
Rewald E. Concetto sostitutivo-inibitorio della eritropoiesi. Riv
Emoterapia ed Immunoematologia 1964;11:149-159 (awarded as honorary
member of the Italian Society of Haematology, prof. P. Introzzi,
Pavia).
Rewald E. Esqueleto y eritropoyesis hiperactiva. Med Atlántico
1964 Apr;3(45):98-100.
Rewald E, Suringar F. Substitutive-Inhibitory therapy
in constitutional nonpherocytic erythrocytic disease. Acta Haematol.
1964;31:303-309.
Rewald E. Bases experimentales para el tratamiento "Substitutivo-Inhibitorio"
en la anemia hemolítica constitucional grave no-esferocítica.
Soc Arg Hematol 1963, Buenos Aires.
Rewald E. Púrpura telangiectásica familiar. Importancia
del hierro de reserva en los estados hemorrágicos. 1963.
Rewald E. Prevención de la eritropoyesis hiperactiva como criterio
terapéutico de la talasemia y demás anemias corpusculares.
Prensa Méd Arg 1963;50:499-500.
Rewald E, Radivoy R. Die Pathologie der gesteigerten Erythropoese
bei haemolytischer Erkrankung. Med Klin 1963 Oct;58(4):1631-1635.
Rewald E, Roqué E, Ibáñez C. Hemorragia hemofílica
con coagulación normal. Med Atlántico 1962 Feb;1(5):
97.
Rodríguez Leyro CA, Loyarte HF, Rewald E. Milzgangrän.
Med Klin 1962 Sep;57(39):1652-1655.
Rewald E. Influence of cancer on red blood cell life span. XIth Congress
Int Soc haematol 1962, Mexico [Proc I:313-316].
Berenblum I, Rewald FE, Trainin N. Failure of bone marrow to interfere
with the augmentation of X-ray leukemogenesis by urethan. J Natl Cancer
Institute 1961;27(6): 1361-7.
Rewald E. Linfadenia. Posibilidades evolutivas. Med Atlántico
1961;1(1):22.
Rewald E. Die Letterer-Christiansche Erkrankung, in Heilmeyer L, Schoen
R, De Rudder B (eds.); Ergebnisse der Inneren Medizin und Kinderheilkunde
(neue Folge) 1960;13:143-174.
Rewald E. Physiopathologie der Letterer-Christianschen Erkrankung.
Aerztl. Wschr. 1959;14(10):177-178.
Rewald E. Fisiopatología y pronóstico de la enfermedad
de Letterer-Christian. Med Panamericana 1959 Set 15 13(6): 251-255.
Rewald E. Ensayos con un nuevo citostático. Prensa Médica
Argentina 1959;46(28):1778-1782.
Rewald E. Diaethyldioxystilben-diphosphat in der Myelom-Therapie.
Aerztl Wschr1958 Jan; 13(3):67-9.
Rewald E. Physiology and prognosis of the Letterer-Christian disease.
8th Congress Int Soc Haematol 1958, Rome.
Rewald E, Azcárate V. Manifestaciones Otorrinolaringológicas
en la Enfermedad de Letterer-Christian. V° Congreso Soc Arg Otorrinolaringología.
Mar del Plata, 1958.
Rewald E. El tratamiento del mieloma múltiple con difosfato
de dioxidietilestilbene. Prensa Méd Arg 1957;44(34): 2643-2645.
Rewald E. El empleo del difosfato de dioxidietilestilbene en los dolores
óseos de la leucemia. Medicina 1957;17:90.
Rewald E. Butazolidina y hemopatías. Rev Soc Arg Hematol y
Hemoterapia 1956;6(1):1-6.
Rewald E. La importancia del factor Rh. [Symposium], Soc Arg Ped 1954,
Mar del Plata.
Rewald E. Novocain in der Asthmakrise. Therapie der Gegenwart 1954;5:192-5.
Rewald E. El empleo de la novocaína en clínica médica
especialmente en asma infantil. Tesis de doctorado, Univer- sidad
Nacional 1953 (calif sobresaliente), Buenos Aires